SMTL ID : 7k2w.1

Crystal structure of CTX-M-14 E166A/K234R Beta-lactamase in complex with hydrolyzed cefotaxime

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.40 Å

Oligo State

monomer

Ligands

1 x CEF: CEFOTAXIME, C3' cleaved, open, bound form(Covalent)

CEF.1: 15 residues within 4Å: Chain A: C.42, S.43, N.77, Y.78, S.103, N.105, P.140, N.143, T.189, R.207, T.208, G.209, S.210, G.211, D.212 13 PLIP interactions: 13 interactions with chain A Hydrogen bonds: A:S.43, A:N.77, A:S.103, A:S.103, A:N.105, A:N.143, A:R.207, A:S.210, A:S.210, A:S.210 Water bridges: A:T.208, A:S.210, A:G.211

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Soeung, V. et al., A drug-resistant beta-lactamase variant changes the conformation of its active-site proton shuttle to alter substrate specificity and inhibitor potency. J.Biol.Chem. (2020)

Release Date

2020-11-04

Peptides

Beta-lactamase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Beta-lactamase